Tag: HIV

February 14, 2017 Off

ViiV Healthcare studies on treating HIV with two drug regimen

By Dino Mustafić

ViiV Healthcare, majority-owned by GSK, with Pfizer and Shionogi Limited as shareholders, has announced detailed study results from its phase III programme evaluating the safety and efficacy of switching virologically suppressed patients from a three- or four-drug antiretroviral regimen to a two-drug regimen of dolutegravir (ViiV Healthcare) and rilpivirine (Janssen Sciences Ireland UC).

February 14, 2017 Off

Gilead to present preclinical HIV study at CROI 2017

By Dino Mustafić

Gilead Sciences will present findings from a preclinical study evaluating HIV capsid inhibitors (CAIs) for potential use as a long-acting antiretroviral (ARV) treatment, at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.

December 1, 2015 Off

Number of AIDS deaths among young Asians doubles over past decade – U.N

By Dino Mustafić

The estimated number of adolescents dying of AIDS in the Asia Pacific region has more than doubled since 2005, experts said on Monday, warning of a “hidden epidemic”.

UNICEF urged Asian countries to improve teenagers’ access to testing, saying many young people do not know their HIV status because of parental consent requirements for tests.